NIBSÉÛ·åCell×Ó¿¯½âÎöÌìÈ»ÃâÒßϵͳ
»úÌåÌìÈ»ÃâÒßϵͳʶ±ðºÍ¸ÐÊÜÀ´×ÔvwinµÂÓ®µÄ¸÷ÖÖģʽ·Ö×Ó£¬ÔÚÞ׿¹²¡Ô¸ÐȾÖ²¡ÖÐÆðÖØÒª×÷Óá£ÌìÈ»ÃâÒߵĺËÐÄÊÇ´æÔÚÓÚϸ°ûĤÉÏ»ò°ûÖÊÄÚµÄģʽʶ±ðÊÜÌ壨pRR£©¡£ÉÛ·åʵÑéÊÒÓÚ2014Äê·¢ÏÖpyrinµ°°×£¨ÒÅ´«Í»±äµ¼Ö¼Ò×åÐÔµØÖк£ÈÈ×ÔÑ×Ö¢¼²²¡£©¿ÉÒÔ×÷ΪpRRµ°°×¸ÐÊܶàÖÖ²»Í¬Ï¸¾ú¶¾ËضԻúÌåRho¼Ò×åСGµ°°×µÄÐÞÊκÍʧ»î£¬½ø¶ø½éµ¼¾ÞÊÉϸ°ûÑ×֢СÌ壨inflammasome£©¸´ºÏÎïµÄ×é×°ºÍÏÂÓÎÑ×ÐÔµ°°×øcaspase-1µÄ¼¤»î£¬Æô¶¯¿¹Ï¸¾úÑ×Ö¢·´Ó¦£¨Xu et al., Nature 2014£©¡£×î½ü£¬ËûÃÇÔÚÑó´Ð²®¿Ë»ô¶ûµÂ¾ú£¨Burkholderia cenocepacia£©Öмø¶¨³öÒ»¸öеÄÁùÐÍ·ÖÃÚϵͳЧӦµ°°×£¬¾ßÓÐȫеÄÍѰ±Ã¸»îÐÔ£¬ÐÞÊκÍʧ»îËÞÖ÷Rhoµ°°×£¬¸ÃÐÞÊÎ×÷ÓõĽá¹ûͬÑùÒ²µ¼ÖÂpyrinÑ×֢СÌåµÄ¼¤»îºÍ²¢ÓÕµ¼·Î²¿Ñ×Ö¢·´Ó¦ÒÔÞ׿¹Ï¸¾ú¸ÐȾ£¬±¨µÀ¸ÃÑо¿½á¹ûµÄÂÛÎÄ¡°A Burkholderia Type VI Effector Deamidates Rho GTpases to Activate the pyrin Inflammasome and Trigger Inflammation¡±ÓÚ2016Äê4ÔÂ28ÈÕÔÚCell Host and MicrobeÔÓÖ¾ÔÚÏß·¢±í¡£
Ñó´Ð²®¿Ë»ô¶ûµÂ¾úÒ»ÖÖÌõ¼þÖ²¡µÄ¸ïÀ¶ÊÏÒõÐÔ¾ú£¬Ö÷Òª¸ÐȾ·Î²¿µÄ¾ÞÊÉϸ°û¡£Ñó´Ð²®¿Ë»ô¶ûµÂ¾ú¸ÐȾ½¡¿µÈËÒ»°ã²»»áµ¼ÖÂÑÏÖØµÄ¼²²¡£¬µ«¸ÐȾ·ÎÄÒÖ×ÐÔÏËά»¯£¨cystic fibrosis£©²¡È˻ᵼÖÂÑÏÖØµÄ·Î²¿²¡±ä£¬ÉõÖÁÖÂËÀ¡£ÔÚÁÙ´²²¡È˺ÍСÊó¸ÐȾģÐÍÖУ¬Ñó´Ð²®¿Ë»ô¶ûµÂ¾ú¸ÐȾ×î´óµÄÌØÕ÷ÊÇÓÕµ¼Ç¿Áҵķβ¿Ñ×Ö¢·´Ó¦£¬µ«Æä»úÖÆÒ»Ö±²»Ã÷¡£ÔÚϸ°ûˮƽ£¬Ñó´Ð²®¿Ë»ô¶ûµÂ¾úºÍºÜ¶à²¡Ô¾úÒ»Ñù£¬¸ÐȾ¾ÞÊÉϸ°û»áµ¼ÖÂRho¼Ò×åСGµ°°×µÄʧ»î£¬¼¡¶¯µ°°×ϸ°û¹Ç¼Ü·¢ÉúÎÉÂÒ£¬Ï¸°ûÏÔʾ³öÌØÕ÷ÐÔµÄÐα䣬ÕâÖÖЧӦÍêÈ«ÒÀÀµÓÚϸ¾úµÄÁùÐÍ·ÖÃÚϵͳ£¬¶Ôϸ¾úÔÚ¾ÞÊÉϸ°ûÄÚ´æ»îÖÁ¹ØÖØÒª¡£
ÀûÓÃÉÏÊö¸ÐȾÓÕµ¼µÄϸ°û¹Ç¼Ü±íÐÍ£¬ÉÛ·åʵÑéÊÒºÍÓ¢¹úÅ®Íõ´óѧ£¨Queen¡¯s University£©µÄValvano½ÌÊÚʵÑéÊÒºÏ×÷£¬Í¨¹ýϸ¾úת×ù×ÓÒÅ´«É¸Ñ¡£¬ÕÒµ½Ò»¸öÁùÐÍ·ÖÃÚϵͳµÄЧӦµ°°×£¬ÃüÃûΪTecA£¬Ï¸¾úȱʧ±àÂëTecAµ°°×µÄ»ùÒòºó²»ÄÜÓÕµ¼¾ÞÊÉϸ°û·¢ÉúÌØÕ÷ÐÔϸ°û¹Ç¼Ü±ä»¯¡£ÉÛ·åʵÑéÊÒÔÚ´ËǰµÄÑо¿ÖÐÒÑ·¢ÏÖÑó´Ð²®¿Ë»ô¶ûµÂ¾ú¸ÐȾ¾ÞÊÉϸ°û¿ÉÒÔÓÕµ¼Rho¼Ò×åСGµ°°×ÔÚÒ»¸öÌØ¶¨µÄÌ춬õ£°·²Ð»ù·¢ÉúÍѰ·»¯ÐÞÊΡ£Ë³×ÅÕâ¸öÏßË÷£¬ËûÃÇͨ¹ýһϵÁеÄϸ°ûÉúÎïѧºÍÉúÎﻯѧµÄʵÑ飬֤Ã÷ÁËͨ¹ýÁùÐÍ·ÖÃÚϵͳ·ÖÃÚÖÁËÞÖ÷ϸ°ûÄÚµÄTecAµ°°×¶ÔÓÚϸ¾ú¸ÐȾÓÕµ¼µÄRhoµ°°×ÍѰ·»¯ÐÞÊμÈÊDZØÐèµÄÒ²Êdzä·ÖµÄ¡£Í¨¹ýÐòÁкÍÉúÎïÐÅϢѧ·ÖÎö£¬Ñо¿ÈËÔ±·¢ÏÖTecAÔÚÆäËüһЩ²¡Ôϸ¾úÖÐÒ²´æÔÚͬԴµ°°×£¬²¢ÇҺͺܶàÒÑÖªµÄµ°°×ø»òË®½âøÀàËÆ£¬TecA¼Ò×åµÄµ°°×ÐòÁÐÖк¬ÓÐÒ»¸ö±£ÊصÄCys-His-Asp´ß»¯ÈýÁªÌ壬ͻ±äÕâЩ´ß»¯Î»µã²Ð»ù¶¼»áʹµÃTecA¼°ÆäͬԴµ°°×µ°°×ɥʧ¶ÔRhoµ°°×µÄÍѰ·ÐÞÊÎÄÜÁ¦¡£Rho¼Ò×åСGµ°°×°üÀ¨RhoA, Rac1ºÍCdc42Èý¸öÖ÷Òª³ÉÔ±£¬½øÒ»²½µÄʵÑé½á¹û±íÃ÷£¬TeA¶ÔRac1µÄÍѰ·ÐÞÊÎÊǵ¼Ö¾ÞÊÉϸ°û¹Ç¼Ü±ä»¯µÄÔÒò£¬¶øÆä¶ÔRhoAµ°°×µÄÐÞÊκÍʧ»îÔò½éµ¼ÁËϸ¾ú¸ÐȾµ¼ÖµÄpyrinÑ×֢СÌåµÄ¼¤»î¡£
×îºó£¬ÔÚÑó´Ð²®¿Ë»ô¶ûµÂ¾úµÄСÊó¸ÐȾģÐÍÖУ¬ÉÛ·åÍŶÓÑо¿·¢ÏÖ£¬TecA¶ÔRhoµ°°×µÄÍѰ·»¯ÐÞÊÎºÍÆäÓÕµ¼µÄpyrinÑ×֢СÌåͨ·µÄ»î»¯ÊÇСÊó·¢ÉúÑÏÖØµÄ·Î²¿Ñ×Ö¢·´Ó¦µÄ¾ö¶¨ÒòËØ£¬²¢ÇÒÕâÖÖÑ×Ö¢·´Ó¦¶ÔСÊóÄܹ»Çå³ýÑó´Ð²®¿Ë»ô¶ûµÂ¾ú¸ÐȾºÍÌá¸ß¸ÐȾºóµÄ´æ»îÂÊÒ²ÓÐÖØÒª×÷Óá£
¸ÃÑо¿ÎªÊ×´ÎÔÚ²®¿Ë»ô¶ûµÂ¾úÊôÖз¢Ïֺͼø¶¨ÁùÐÍ·ÖÃÚϵͳЧӦµ°°×£¬²¢ÇÒTecAÒ²ÊÇÊ׸ö¾ßÓÐÌ춬õ£°·ÍѰ±Ã¸»îÐԵIJ¡Ô¾úЧӦµ°°×¡£ºÍ¾ø´ó¶àÊýÁùÐÍ·ÖÃÚϵͳЧӦµ°°××÷ÓÃÓÚϸ¾ú¾ºÕùÕß²»Í¬£¬TecAÊÇÓɲ¡Ô¾ú·ÖÃÚµ½ËÞÖ÷°ûÖÁÄÚ·¢»Ó¶¾Á¦×÷Óõġ£ÁíÍ⣬±¾Ñо¿Ò²½ÒʾÁËÑó´Ð²®¿Ë»ô¶ûµÂ¾ú¸ÐȾÓÕµ¼·Î²¿Ñ×Ö¢·´Ó¦µÄ·Ö×Ó»úÖÆ£¬½â¾öÁ˸Ãϸ¾úºÍÏà¹Ø¼²²¡Ñо¿ÖÐÒÅÁôÁ˺ܳ¤Ê±ÆÚµÄÒ»¸öÄÑÌâ¡£
Valvano½ÌÊÚʵÑéÊҵIJ©Ê¿ºóDaniel F. Aubert£¬±±¾©ÉúÃü¿ÆÑ§Ñо¿ËùÉÛ·åʵÑéÊҵIJ©Ê¿ºóÐìºÆÓëÑî½ÜÁèΪ±¾ÎĹ²Í¬µÚÒ»×÷Õߣ»NIBSÓëÖйúũҵ´óѧÁªºÏÅàÑø²©Ê¿ÉúÊ·ÐñÑ׺͸ßÎÄÇàÒ²¶Ô±¾¹¤×÷ÓÐÖØÒª¹±Ïס£±¾ÎÄÆäËü×÷Õß»¹°üÀ¨NIBSµ°°×ÖÊ×éѧÖÐÐĵÄÀîÁպͳÂÉæ²©Ê¿ÒÔ¼°ValvanoʵÑéÊÒµÄÑо¿ÉúFabiana Bisaro¡£Valvano½ÌÊÚºÍÉ۷岩ʿΪ±¾ÎĹ²Í¬Í¨Ñ¶×÷Õߣ¬ÉÛ·åʵÑéÊÒµÄÑо¿ÓɿƼ¼²¿973ºÍ±±¾©ÊÐÕþ¸®ÒÔ¼°ÃÀ¹úHHMI×ÊÖú£¬ÔÚ±±¾©ÉúÃü¿ÆÑ§Ñо¿ËùÍê³É¡£
ÔÎÄÕªÒª£º
A Burkholderia Type VI Effector Deamidates Rho GTpases to Activate the pyrin Inflammasome and Trigger Inflammation
Burkholderia cenocepacia is an opportunistic pathogen of the cystic fibrosis lung that elicits a strong inflammatory response. B. cenocepacia employs a type VI secretion system (T6SS) to survive in macrophages by disarming Rho-type GTpases, causing actin cytoskeletal defects. Here, we identified TecA, a non-VgrG T6SS effector responsible for actin disruption. TecA and other bacterial homologs bear a cysteine protease-like catalytic triad, which inactivates Rho GTpases by deamidating a conserved asparagine in the GTpase switch-I region. RhoA deamidation induces caspase-1 inflammasome activation, which is mediated by the familial Mediterranean fever disease protein pyrin. In mouse infection, the deamidase activity of TecA is necessary and sufficient for B. cenocepacia-triggered lung inflammation and also protects mice from lethal B. cenocepacia infection. Therefore, Burkholderia TecA is a T6SS effector that modifies a eukaryotic target through an asparagine deamidase activity, which in turn elicits host cell death and inflammation through activation of the pyrin inflammasome.